Galderma, the leading company solely dedicated to advancing the future of dermatology, premiered the positive phase III results from the OLYMPIA 2 trial evaluating the efficacy, safety, pharmacokinetics and immunogenicity of nemolizumab compared with placebo in adult patients with prurigo nodularis.
Incyte announced new 104-week results from the pivotal Phase 3 TRuE-V clinical trial program evaluating Opzelura® cream 1.5% in patients 12 years of age and older with nonsegmental vitiligo, a chronic autoimmune disease characterized by depigmentation of skin.
Real estate development firm Sterling Bay launches life sciences division starting with Lincoln Yards, a 320,000 square foot site on the Chicago River.
In spite of a tumultuous economy, many life science companies have started the year off strong. With plans to expand its team and pipeline in the coming year, Takeda is one of them.
Takeda Oncology Invests in Talent, Pipeline Growth Despite Turbulent Market Read More »
En este Short conoceremos una nueva capa descubierta en el interior de nuestro planeta. …
Descubren una nueva parte en el interior de la Tierra Read More »
En este Short examinamos el caso de ciertas galaxias muy antiguas que poseían una masa que no deberían tener. …
Seis galaxias con una masa imposible para su época Read More »
Encontrar el sentido detrás de lo “siniestro”. La historia personal de un neurocientífico en Buenos Aires que se muda para cuidar de su padre, quien empezaba a padecer demencia.
El rover robótico Curiosity, de la NASA, que circula por la superficie de Marte desde 2012, hizo esta fotografía del cielo marciano el 27 de enero de 2023. En ella destaca una llamativa nube iridiscente cuya forma recuerda mucho a la de una pluma de ave. Estudiar las tonalidades de la …
The digital therapeutics firm is considering a sale, merger, divestiture, licensing, or seeking additional financing.
Pear, tight on cash, considers strategic alternatives Read More »
For Daiichi Sankyo, recent results from the Phase III CLEAR trial of Esperion Therapeutics’ Nexletol (bempedoic acid) were not convincing enough to trigger a milestone payment.
Esperion-Daiichi Sankyo Partnership Saga Continues with Payment Spat Read More »
